Project Number 5U01AG050636-03 Agency/Funding Organization NIA Funding Year 2017 View Full Project Details for PRECLINICAL DEVELOPMENT OF A SELECTIVE SUPPRESSOR OF NEUROINFLAMMATION FOR MCI/AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) f. Inflammation Researcher and Organization Principal Investigator VAN ELDIK, LINDA J Principal Investigator First Name LINDA Principal Investigator Last Name VAN ELDIK Awardee Organization UNIVERSITY OF KENTUCKY Awardee State Kentucky Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-12-015: Alzheimer's Disease Drug Development Program (U01) FY Overall Cost $1,468,850 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA
